Correction to: Gene Therapy https://doi.org/10.1038/s41434-025-00534-9, published online 10 April 2025
In this article the Competing Interest statement was previously given as “An international patent application has been filed based on this work (PCT/EP2024/058078). R.R., E.H., H.Z. and A.B. are shareholders in MicThera.” but should be updated to “An international patent application has been filed based on this work (PCT/EP2024/ 058078). R.R., E.H., H.Z. and A.B. are shareholders in CERimmune Therapeutics.”.
This correction is initiated solely on account of the company’s name change.
The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Heiss, C.N., Riise, R., Hanse, E. et al. Correction: Expression of anti-amyloid CARs in microglia promotes efficient and selective phagocytosis of Aβ1‒42. Gene Ther 32, 572 (2025). https://doi.org/10.1038/s41434-025-00562-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41434-025-00562-5
